Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

NCT06391190 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Cervical Carcinoma
Concurrent Chemoradiotherapy
Immunotherapy

Interventions

DRUG: Albumin-Bound Paclitaxel, cisplatin, Sintilimab

Sponsor

RenJi Hospital